BMC Endocrine Disorders is calling for submissions to our Collection, The impact of gut microbiota and diet on metabolic diseases and cardiometabolic health.
The gut microbiome, a complex community of microorganisms residing in the gastrointestinal tract, plays a pivotal role in human health, influencing various metabolic processes. Recent research has highlighted the intricate relationship between gut microbiota and cardiometabolic diseases, such as obesity, type 2 diabetes, and cardiovascular disorders. These microbes participate in the digestion of dietary components, produce metabolites like short-chain fatty acids (SCFAs), and modulate host metabolism, thereby affecting the risk and progression of cardiometabolic conditions.
Understanding the impact of the gut microbiome on cardiometabolic health is essential for developing innovative therapeutic strategies. Recent advances in microbiome research have identified specific microbial pathways associated with cardiometabolic traits, paving the way for targeted interventions, such as the use of probiotics and prebiotics. By elucidating the mechanisms through which gut microbes influence metabolic health, researchers can contribute to the development of personalized nutrition and microbiome-based therapies that may significantly improve patient outcomes.
Continued exploration of the gut microbiome's influence on cardiometabolic diseases holds promise for future breakthroughs in prevention and treatment. As research progresses, we may see the emergence of novel biomarkers for early detection of metabolic disorders and the identification of specific microbial signatures that could inform dietary and therapeutic strategies. This ongoing investigation may lead to the establishment of gut microbiome modulation as a key component in the management of cardiometabolic diseases.
Topics that are welcome include, but are not limited to, the following:
- Gut microbiota and cardiovascular disease risk factors
- The association between gut microbiota, diet, and cardiometabolic disease risk
- Role of Short-Chain Fatty Acids (SCFAs) in metabolic health
- Gut microbial pathways influencing cardiometabolic health
- Probiotics and prebiotics in cardiometabolic interventions
- Microbial signatures and metabolic syndrome
This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Image credit: © Anatomy Insider / Stock.adobe.com
